ArticlebioRxiv : the preprint server for biology2025
Runx/Cbfβ regulates the development of tolerogenic Thetis cells.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Establishing immune tolerance to gut microbiota and food antigens upon first exposures during early life is essential to prevent inflammatory bowel diseases and food allergy and depends on induction of peripherally induced Rorgt expressing regulatory T (Rorgt+ pTreg) cells. Recent studies have identified a critical role for Rorgt expressing antigen-presenting cells (APC), Thetis cells (TCs), in peripheral regulatory T (pTreg) cell differentiation and tolerance to food and commensal microbes. TCs encompass four distinct subsets, and a subset of TCs, TC IV induces pTreg differentiation, but the transcription factors that control their differentiation are not fully known. Here, using orthogonal genetic approaches to impair Runx/Cbfb activity, we show that development of specific TCs subsets is regulated by Runx/Cbfb transcriptional factor complexes. While attenuated Runx3 by germline mutations resulted in a severe reduction of all Rorgt+ APCs, mice lacking one of two Cbb splicing variants, Cbfb2, exhibited a loss of TC II, III and TC IV subsets with associated loss of Rorgt+ pTreg cells. Conditional inactivation of Runx1 and Runx3 genes by CD11c-Cre led to a specific loss of TC III and TC IV subsets. Strikingly, CD11c-Cre driven transgenic Runx expression, particularly Runx1, led to enhanced TC IV differentiation and thus Rorgt+ pTreg cells. Furthermore, transgenic Cbfb2 by CD11c-Cre recovered only TC IV subset with restoration of Rorg;t+ pTreg in Cbfb2-deficient mice. Collectively, our findings establish a critical pathway for TC IV differentiation and provide new insights into therapeutic interventions to promote Rorgt+ pTreg induction in autoimmune and inflammatory diseases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.